Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» prostate cancer
prostate cancer
U.S. FDA denies new use for Glaxo's Avodart
Marketwatch
Wed, 01/26/11 - 09:28 pm
FDA
GSK
Avodart
prostate cancer
First Five-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer
Tue, 01/11/11 - 04:56 pm
Cyberknife
Accuray
prostate cancer
First Five-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer
Tue, 01/11/11 - 04:56 pm
Cyberknife
Accuray
prostate cancer
Amgen Exec: “Clearly Superior” Prostate Cancer Drug Will Be Huge
Forbes
Mon, 01/10/11 - 08:04 pm
prostate cancer
Amgen
Prolia
Xgeva
Dendreon Reports Provenge Sales, Plans for Expansion
Bloomberg
Sat, 01/8/11 - 11:50 am
Dendreon
Provenge
prostate cancer
Dendreon Bringing Provenge to Europe
TheStreet.com
Fri, 01/7/11 - 09:57 am
Provenge
Europe
Dendreon
vaccines
prostate cancer
Yet Another Group Sues Medicare Over Provenge
Pharmalot
Thu, 01/6/11 - 01:16 pm
Medicare
Provenge
Dendreon
prostate cancer
Amgen Drug Meets Primary Endpoint
Yahoo/Zacks
Sat, 12/18/10 - 12:35 pm
Xgeva
Amgen
prostate cancer
Zometa
Amgen Celebration May be Premature
Minyanville
Tue, 12/14/10 - 09:46 pm
Amgen
prostate cancer
Xgeva
Amgen shares rise after positive study data
Marketwatch
Tue, 12/14/10 - 11:11 am
Amgen
prostate cancer
Xgeva
Amgen Drug Prevents Prostate Cancer From Spreading To Bone
Forbes
Mon, 12/13/10 - 09:14 pm
Amgen
prostate cancer
Xgeva
Advisory Votes Against Expanding Use of GSK’s, Merck’s Prostate Drugs: Biotech's Latest Tribulations
Seeking Alpha
Sun, 12/5/10 - 11:52 am
GSK
Merck
Avodart
enlarged prostate
prostate cancer
Proscar
Orexigen
obesity
Contrave
Novartis
JNJ
Merck KGaA
Glaxo Fails to Win Panel’s Vote for Wider Avodart Use
Bloomberg
Wed, 12/1/10 - 09:02 pm
GSK
Avodart
advisory panels
prostate cancer
Merck's Proscar Fails to Win U.S. FDA Panel's Backing for Prostate Cancer
Bloomberg
Wed, 12/1/10 - 05:55 pm
Merck
Proscar
FDA
prostate cancer
FDA disputes prostate drugs' risk-cutting power
Fierce Pharma
Tue, 11/30/10 - 10:59 am
FDA
GSK
prostate cancer
Avodart
Merck
Proscar
Glaxo’s Avodart Faces FDA Questions on Prostate Cancer Benefits
Bloomberg
Mon, 11/29/10 - 09:55 am
GSK
Avodart
prostate cancer
Aeterna Zentaris Presents Encouraging Preclinical Data On Two Novel Orally Active Anti-Cancer Compounds At Major Conference In Germany
Medical News Today
Sat, 11/20/10 - 01:17 pm
Aeterna Zentaris
AEZS-129
AEZS-132
cancer
melanoma
lung cancer
prostate cancer
colon cancer
breast cancer
endometrial cancer
Exelixis: Up 32% With Room to Run
Motley Fool
Sat, 11/20/10 - 12:08 pm
XL184
ovarian cancer
prostate cancer
Exelixis
Bristol-Myers Squibb
Dendreon Gains on U.S. Panel’s Backing for Provenge Cancer Drug
Bloomberg
Thu, 11/18/10 - 09:36 am
Dendreon
prostate cancer
Provenge
Summary Box: Medicare advisers say $93,000 cancer drug Provenge helps patients live longer
Yahoo/AP
Wed, 11/17/10 - 06:26 pm
Provenge
Dendreon
vaccines
prostate cancer
Pages
« first
‹ previous
…
21
22
23
24
25
26
27
28
29
…
next ›
last »